Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/22/21
New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona's ABO-102 Gene TherapyGlobeNewsWire • 02/12/21
Abeona Therapeutics Announces Clinical Investigator Webinar to Review ABO-102 and ABO-101 Clinical Data Presented at the 17th Annual WORLDSymposium™GlobeNewsWire • 02/02/21
Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)GlobeNewsWire • 01/25/21
Do Options Traders Know Something About Abeona (ABEO) Stock We Don't?Zacks Investment Research • 01/12/21
Abeona Therapeutics Announces Acceptance of Late-Breaker Abstracts Highlighting New Clinical Data for Novel AAV-based Gene Therapies in MPS IIIA and MPS IIIB at WORLDSymposium™GlobeNewsWire • 12/21/20
Abeona Therapeutics Announces the Appointment of Michael Amoroso as Chief Operating OfficerGlobeNewsWire • 10/27/20
Abeona Therapeutics’ Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership PlanGlobeNewsWire • 10/06/20
Abeona Therapeutics and Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 DiseaseGlobeNewsWire • 08/17/20
Abeona Therapeutics Reports Second Quarter Financial Results and Business UpdatesGlobeNewsWire • 08/10/20
Abeona Therapeutics Announces Two Presentations Related to Its RDEB Clinical Program at the Society for Pediatric Dermatology 45th Annual MeetingGlobeNewsWire • 07/10/20
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Commercial OfficerGlobeNewsWire • 07/09/20
Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITAL™ Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III StudiesGlobeNewsWire • 07/08/20
Abeona Therapeutics Announces Upcoming Data Presentations at the Society for Pediatric Dermatology 45th Annual MeetingGlobeNewsWire • 06/18/20
Abeona Therapeutics Further Strengthens Board with Appointment of Two New Independent DirectorsGlobeNewsWire • 06/17/20
Is Abeona Therapeutics (ABEO) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 05/28/20
Abeona Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 04/21/20